New cancer clinical trial: Durvalumab With Trastuzumab and Pertuzumab in HER2-Enriched Breast Cancer

Published on: January 29, 2019 at 12:00PM
Condition:   Breast Cancer
Interventions:   Drug: Durvalumab;   Drug: Trastuzumab;   Drug: Pertuzumab
Sponsors:   Jenny C. Chang, MD;   AstraZeneca
Not yet recruiting
http://bit.ly/2t3lCAJ